Cargando…
Intake of Lactobacillus delbrueckii (pExu:hsp65) Prevents the Inflammation and the Disorganization of the Intestinal Mucosa in a Mouse Model of Mucositis
5-Fluorouracil (5-FU) is an antineoplastic drug that causes, as a side effect, intestinal mucositis, acute inflammation in the small bowel. The Heat Shock Protein (Hsp) are highly expressed in inflammatory conditions, developing an important role in immune modulation. Thus, they are potential candid...
Autores principales: | Barroso, Fernanda Alvarenga Lima, de Jesus, Luís Cláudio Lima, de Castro, Camila Prosperi, Batista, Viviane Lima, Ferreira, Ênio, Fernandes, Renata Salgado, de Barros, André Luís Branco, Leclerq, Sophie Yvette, Azevedo, Vasco, Mancha-Agresti, Pamela, Drumond, Mariana Martins |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7824804/ https://www.ncbi.nlm.nih.gov/pubmed/33466324 http://dx.doi.org/10.3390/microorganisms9010107 |
Ejemplares similares
-
Paraprobiotics and Postbiotics of Lactobacillus delbrueckii CIDCA 133 Mitigate 5-FU-Induced Intestinal Inflammation
por: Batista, Viviane Lima, et al.
Publicado: (2022) -
Lactobacillus delbrueckii CIDCA 133 Ameliorates Chemotherapy-Induced Mucositis by Modulating Epithelial Barrier and TLR2/4/Myd88/NF-κB Signaling Pathway
por: Barroso, Fernanda Alvarenga Lima, et al.
Publicado: (2022) -
Probiogenomics of Lactobacillus delbrueckii subsp. lactis CIDCA 133: In Silico, In Vitro, and In Vivo Approaches
por: de Jesus, Luís Cláudio Lima, et al.
Publicado: (2021) -
Probiotics, Prebiotics, Synbiotics, and Paraprobiotics as a Therapeutic Alternative for Intestinal Mucositis
por: Batista, Viviane Lima, et al.
Publicado: (2020) -
Vector Development Timeline for Mucosal Vaccination and Treatment of Disease Using Lactococcus lactis and Design Approaches of Next Generation Food Grade Plasmids
por: de Castro, Camila Prosperi, et al.
Publicado: (2018)